Deschloroetizolam
Deschloroetizolam is a thienotriazolodiazepine designer benzodiazepine, the dechlorinated analogue of etizolam. It is markedly less potent than etizolam but shares the same sedative, anxiolytic and amnestic profile. There is no formal human clinical data.
01 Overview
Deschloroetizolam is an analogue of etizolam lacking the chlorine substituent, which reduces its potency. It appeared on the research-chemical market as a legal alternative to controlled benzodiazepines and has never been studied as a medicine.
It is a GABA-A positive allosteric modulator. All descriptions of its effects and risks come from user reports and analogy to etizolam rather than controlled study. Unregulated purity and dosing make overdose and dependence realistic concerns.
02 Mechanism
Positive allosteric modulation of GABA-A receptors at the benzodiazepine site, increasing inhibitory tone.
03 Dosing
| Tier | Dose | Route | Notes |
|---|---|---|---|
| Light | 2–5 mg | Oral | Less potent than etizolam; potency estimates are approximate. |
| Common | 5–10 mg | Oral | Sedation and amnesia increasingly likely. |
04 Effects
| Effect | Magnitude | Evidence | |
|---|---|---|---|
| AnxiolysisReduction in anxiety reported by users. | Anecdotal | ||
| SedationDrowsiness and reduced arousal. | Anecdotal | ||
| Muscle relaxationReduced muscle tension typical of the class. | Anecdotal |
05 Side effects
| Effect | Severity | Frequency | Evidence | Countermeasures |
|---|---|---|---|---|
| Physical dependenceTolerance and dependence develop with repeated use; withdrawal may include seizures. | Severe | Common with regular use | Observational | |
| Blackouts / anterograde amnesiaMemory gaps during intoxication. | Moderate | Common at higher doses | Anecdotal | |
| Additive respiratory depressionDangerous with opioids or alcohol. | Life-threatening | High risk in combination | Observational |